0001104659-21-056732.txt : 20210428
0001104659-21-056732.hdr.sgml : 20210428
20210428201829
ACCESSION NUMBER: 0001104659-21-056732
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210427
FILED AS OF DATE: 20210428
DATE AS OF CHANGE: 20210428
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SQUINTO STEPHEN P
CENTRAL INDEX KEY: 0001231954
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39044
FILM NUMBER: 21866543
MAIL ADDRESS:
STREET 1: C/O ALEXION PHARMACEUTICALS INC
STREET 2: 352 KNOTTER DRIVE
CITY: CHESHIRE
STATE: CT
ZIP: 06410
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SpringWorks Therapeutics, Inc.
CENTRAL INDEX KEY: 0001773427
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 WASHINGTON BOULEVARD
CITY: STAMFORD
STATE: CT
ZIP: 06902
BUSINESS PHONE: 203-883-9490
MAIL ADDRESS:
STREET 1: 100 WASHINGTON BOULEVARD
CITY: STAMFORD
STATE: CT
ZIP: 06902
4
1
tm2114187d3_4.xml
FORM 4
X0306
4
2021-04-27
0
0001773427
SpringWorks Therapeutics, Inc.
SWTX
0001231954
SQUINTO STEPHEN P
C/O SPRINGWORKS THERAPEUTICS, INC.
100 WASHINGTON BLVD.
STAMFORD,
CT
06902
1
0
1
0
Common Stock
2021-04-27
4
S
0
201
75.0498
D
144959
D
Common Stock
2021-04-28
4
S
0
19231
76.2018
D
125728
D
The sale transaction reported on this Form 4 was effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $75.00 to $75.10, inclusive.
Includes shares of common stock held by a trust (i) the beneficiaries of which are the Reporting Person's children and (ii) of which the Reporting Person is the trustee.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $75.00 to $77.72, inclusive.
/s/ Francis I. Perier, Jr as Attorney-in-Fact
2021-04-28